Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 8, 2013, Pages 1293-1303

  Lin, Erh Hsuan ^a   Chang, Hsiang Yi ^a   Yeh, Shauh Der ^b   Yang, Kuang Yao ^a,c   Hu, Huei Sin ^a   Wu, Cheng Wen ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

2 Adrenergic receptor; Gene therapy; LPS induced acute lung injury; Lung epithelium; Nanoparticle

Indexed keywords

ACUTE LUNG INJURY; ALVEOLAR EPITHELIAL CELLS; CLINICAL APPLICATION; INFLAMMATORY CYTOKINES; INTRAVENOUS INJECTIONS; LUNG EPITHELIUM; PROTEIN CONCENTRATIONS; TRANSGENE EXPRESSION;

GENE THERAPY; MAMMALS; NANOPARTICLES;

BIOLOGICAL ORGANS;

BETA 2 ADRENERGIC RECEPTOR; DNA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NANOPARTICLE; POLYETHYLENEIMINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; HISTOPATHOLOGY; IN VIVO GENE TRANSFER; LUNG ALVEOLUS EPITHELIUM; LUNG CLEARANCE; LUNG FLUID; LUNG LAVAGE; MOUSE; NONHUMAN; PILOT STUDY; SURVIVAL RATE; TRANSGENE;

MUS; RODENTIA;

GENE THERAPY; LPS-INDUCED ACUTE LUNG INJURY; LUNG EPITHELIUM; NANOPARTICLE; Β2-ADRENERGIC RECEPTOR;

ACUTE LUNG INJURY; ANIMALS; DNA; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; LUNG; MICE; NANOPARTICLES; POLYETHYLENEIMINE; RECEPTORS, ADRENERGIC, BETA;

EID: 84886421129     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.05.004     Document Type: Article

References (45)

1. Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011, 6:147-163.
2. Raghavendran K., Pryhuber G.S., Chess P.R., Davidson B.A., Knight P.R., Notter R.H. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem 2008, 15:1911-1924.
3. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693.
4. Gao S.F., Perkins G.D., Gates S., Young D., McAuley D.F., Tunnicliffe W., et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012, 379:229-235.
5. Matthay M.A., Brower R.G., Carson S., Douglas I.S., Eisner M., Hite D., et al. Randomized, placebo-controlled clinical trial of an aerosolized beta-2 agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184:561-568.
6. Boulaiz H., Marchal J.A., Prados J., Melguizo C., Aranega A. Non-viral and viral vectors for gene therapy. Cell Mol Biol 2005, 51:3-22.
7. Goula D., Benoist C., Mantero S., Merlo G., Levi G., Demeneix B.A. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 1998, 5:1291-1295.
8. Zou S.M., Erbacher P., Remy J.S., Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2000, 2:128-134.
9. Bragonzi A., Boletta A., Biffi A., Muggia A., Sersale G., Cheng S.H., et al. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther 1999, 6:1995-2004.
10. Bonnet M.E., Erbacher P., Bolcato-Bellemin A.L. Systemic delivery of DNA or sirna mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm Res 2008, 25:2972-2982.
11. Mutlu G.M., Factor P. Alveolar epithelial beta2-adrenergic receptors. Am J Respir Cell Mol Biol 2008, 38:127-134.
12. Perkins G.D., Nathani N., McAuley D.F., Gao F., Thickett D.R. In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax 2007, 62:36-42.
13. Maris N.A., de Vos A.F., Dessing M.C., Spek C.A., Lutter R., Jansen H.M., et al. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005, 172:878-884.
14. Perkins G.D., Gao F., Thickett D.R. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 2008, 63:215-220.
15. McGraw D.W., Fukuda N., James P.F., Forbes S.L., Woo A.L., Lingrel J.B., et al. Targeted transgenic expression of beta(2)-adrenergic receptors to type ii cells increases alveolar fluid clearance. Am J Physiol Lung Cell Mol Physiol 2001, 281:L895-L903.
16. Factor P., Adir Y., Mutlu G.M., Burhop J., Dumasius V. Effects of beta2-adrenergic receptor overexpression on alveolar epithelial active transport. J Allergy Clin Immunol 2002, 110:S242-S246.
17. Dumasius V., Sznajder J.I., Azzam Z.S., Boja J., Mutlu G.M., Maron M.B., et al. Beta(2)-adrenergic receptor overexpression increases alveolar fluid clearance and responsiveness to endogenous catecholamines in rats. Circ Res 2001, 89:907-914.
18. Mutlu G.M., Dumasius V., Burhop J., McShane P.J., Meng F.J., Welch L., et al. Upregulation of alveolar epithelial active NA+ transport is dependent on beta2-adrenergic receptor signaling. Circ Res 2004, 94:1091-1100.
19. Lin E.H., Keramidas M., Rome C., Chiu W.T., Wu C.W., Coll J.L., et al. Lifelong reporter gene imaging in the lungs of mice following polyethyleneimine-mediated sleeping-beauty transposon delivery. Biomaterials 2011, 32:1978-1985.
20. Hong C.F., Chou Y.T., Lin Y.S., Wu C.W. MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem 2009, 284:19613-19622.
21. Mutlu G.M., Machado-Aranda D., Norton J.E., Bellmeyer A., Urich D., Zhou R., et al. Electroporation-mediated gene transfer of the NA+,K+-ATPpase rescues endotoxin-induced lung injury. Am J Respir Crit Care Med 2007, 176:582-590.
22. Matute-Bello G., Downey G., Moore B.B., Groshong S.D., Matthay M.A., Slutsky A.S., et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011, 44:725-738.
23. Bassford C.R., Thickett D.R., Perkins G.D. The rise and fall of beta-agonists in the treatment of ARDS. Crit Care 2012, 16:208.
24. Thompson B.T. Beta-agonists for ARDS: the dark side of adrenergic stimulation?. Lancet 2012, 379:196-198.
25. Perkins G.D., McAuley D.F. Pro: beta-agonists in acute lung injury-the end of the story?. Am J Respir Crit Care Med 2011, 184:503-504.
26. Papazian L. Con: beta2-adrenergic agonists in ALI/ARDS-not recommended or potentially harmful?. Am J Respir Crit Care Med 2011, 184:504-506.
27. Ware L.B., Matthay M.A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163:1376-1383.
28. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010, 9:615-627.
29. Champion J.A., Walker A., Mitragotri S. Role of particle size in phagocytosis of polymeric microspheres. Pharm Res 2008, 25:1815-1821.
30. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J Control Release 2010, 145:182-195.
31. Goula D., Remy J.S., Erbacher P., Wasowicz M., Levi G., Abdallah B., et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998, 5:712-717.
32. Bragonzi A., Dina G., Villa A., Calori G., Biffi A., Bordignon C., et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000, 7:1753-1760.
33. Goula D., Becker N., Lemkine G.F., Normandie P., Rodrigues J., Mantero S., et al. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 2000, 7:499-504.
34. Chollet P., Favrot M.C., Hurbin A., Coll J.L. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med 2002, 4:84-91.
35. Jeong G.J., Byun H.M., Kim J.M., Yoon H., Choi H.G., Kim W.K., et al. Biodistribution and tissue expression kinetics of plasmid DNA complexed with polyethylenimines of different molecular weight and structure. J Control Release 2007, 118:118-125.
36. Regnstrom K., Ragnarsson E.G., Fryknas M., Koping-Hoggard M., Artursson P. Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for nonviral gene delivery. Pharm Res 2006, 23:475-482.
37. Kawakami S., Ito Y., Charoensit P., Yamashita F., Hashida M. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J Pharmacol Exp Ther 2006, 317:1382-1390.
38. Regnstrom K., Ragnarsson E.G., Koping-Hoggard M., Torstensson E., Nyblom H., Artursson P. PEI - a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FASL-mediated cell death in mice. Gene Ther 2003, 10:1575-1583.
39. Gautam A., Densmore C.L., Waldrep J.C. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther 2001, 8:254-257.
40. Rudolph C., Lausier J., Naundorf S., Muller R.H., Rosenecker J. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000, 2:269-278.
41. Beyerle A., Irmler M., Beckers J., Kissel T., Stoeger T. Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications. Mol Pharm 2010, 7:727-737.
42. Petsch D., Anspach F.B. Endotoxin removal from protein solutions. J Biotechnol 2000, 76:97-119.
43. Helander I.M., Latva-Kala K., Lounatmaa K. Permeabilizing action of polyethyleneimine on Salmonella typhimurium involves disruption of the outer membrane and interactions with lipopolysaccharide. Microbiology 1998, 144(Pt 2):385-390.
44. Taylor C.A., Liu Z., Tang T.C., Zheng Q., Francis S., Wang T.W., et al. Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-kappaB activity and tumor growth in murine models of multiple myeloma. Mol Ther 2012, 20:1305-1314.
45. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol 2009, 9:692-703.